EU Chemicals Strategy Advances Endocrine Society EDC Priorities

As the European Commission makes progress towards implementation of the Chemicals Strategy for Sustainability (CSS), the Endocrine Society continues to provide input to ensure that the strategy modernizes the European Union’s approach to identification and regulation of endocrine-disrupting chemicals (EDCs).

Our members are providing feedback in several different ways, including as a member of the High-Level Roundtable for the Chemicals Strategy. On November 25, the members of the Roundtable met to approve a report outlining the group’s discussions concerning enforcement and compliance of chemicals legislation.

Endocrine Society members will be vital to ongoing discussions about how best to manage human health and ecological hazards from EDCs.

The report describes the requirements of a successful enforcement and compliance structure aligned with the CSS and identifies barriers in enforcement and compliance preventing achievement of the CSS goals. We contributed to the report by offering suggestions aimed at improving the dialogue between enforcement authorities and scientists, especially in areas where new science-based legislation and regulations are forthcoming, such as for EDCs.

Meanwhile, the European Commission collected broader public input via an Open Public Consultation on the Targeted Revision of the Regulation on Classification, Labelling and Packaging of Substances and Mixtures (CLP). The CLP regulation identifies chemical hazards among different classes of substances and prescribes labeling requirements to disclose information from manufacturers to consumers about potential hazards in products.

Importantly, the Commission proposes that EDCs are considered a new hazard class that will need to be addressed in the CLP regulation. Our expert EU Task Force developed a response to the consultation focused on the need to establish clear categories for the classification of EDCs depending on the level of evidence available for each substance.

Our expert EU Task Force developed a response to the consultation focused on the need to establish clear categories for the classification of EDCs depending on the level of evidence available for each substance.

The Chemicals Strategy for Sustainability is an important component of the EU Green Deal and includes many proposed actions over the coming years to achieve a zero-pollution future. Endocrine Society members will be vital to ongoing discussions about how best to manage human health and ecological hazards from EDCs.

To become involved in the Society’s EDC advocacy, send a message to Joe Laakso, director of science policy at: [email protected]

You may also like

  • Advocacy in Action – November 2025

    Prescription Drug Pricing Update: Society Continues Advocacy to Lower Price and Out-of-Pocket Costs of Medications    Last month, the Trump Administration and a major retailer took steps to address high prescription drug prices. On September 30, the Trump Administration announced the creation of “TrumpRx,” a consumer website where Americans can buy medications at a discounted price….

  • Endocrine Society Rallies for Medical Research 

    As of this posting, the U.S. House of Representatives and Senate are not close to agreement on an appropriations bill that would fund the Department of Health and Human Services, the National Institutes of Health (NIH), and other federal health agencies for fiscal year 2026, which begins on October 1. Consequently, a partial federal government shutdown…